elliseamos wrote:Isn't the joke on you that (1) you've paid $8 dollars to a billionaire and (2) to use the billionaire's product?
This current game seems like all musk winning and little else.
Just think: if he can get a million people to maintain paid verification subscriptions for 40 years, the service will have earned almost as much as Twitter’s advertising brought in last year.
Has usage/traffic on Twitter decreased?
I understand the advertisement announcements impact the immediate bottom line, but I'm pretty sure twitter is not going away.
elliseamos wrote:Isn't the joke on you that (1) you've paid $8 dollars to a billionaire and (2) to use the billionaire's product?
This current game seems like all musk winning and little else.
Just think: if he can get a million people to maintain paid verification subscriptions for 40 years, the service will have earned almost as much as Twitter’s advertising brought in last year.
Has usage/traffic on Twitter decreased?
I understand the advertisement announcements impact the immediate bottom line, but I'm pretty sure twitter is not going away.
Twitter usage is at an all time high, honestly it's never been better in terms of content, but Yoel left last night so most of the technical leaders are gone now and now they are going to have territorial fights alongside the policy issues. This could have been solved with the "official" secondary tag... they had it in their hands... but Elon gonna Elon.
"The fatal flaw of all revolutionaries is that they know how to tear things down but don't have a f**king clue about how to build anything."
BurtReynolds wrote:Sorry I posted fake news in the last one. They've issued a fact check:
Gentlemen, I have a modest proposal...
Another thing I find interesting about this is the midst of all the Mickey style "lol lmao" responses is that this exposes a pretty serious issue with how algo-driven investing works today that seems to be getting lost in the blue check schadenfreude. (Not to mention that the recovery of that lost value is gonna come at the expense of the customers who need those drugs to survive.)
